Interleukin-27 Receptor Limits Atherosclerosis in Ldlr −/− Mice

Autor: Sibylle von Vietinghoff, Mitchell Kronenberg, Gisen Kim, Christiaan J. M. Saris, Klaus Ley, Ekaterina K. Koltsova, Katheleen M. Lloyd
Rok vydání: 2012
Předmět:
Zdroj: Circulation Research. 111:1274-1285
ISSN: 1524-4571
0009-7330
DOI: 10.1161/circresaha.112.277525
Popis: Rationale: Atherosclerosis is a chronic inflammatory disease of the arterial wall. Several proinflammatory cytokines are known to promote atherosclerosis, but less is known about the physiological role of anti-inflammatory cytokines. Interleukin (IL)-27 is a recently discovered member of the IL-6/IL-12 family. The IL-27 receptor is composed of IL-27 receptor A (WSX-1) and gp130 and is required for all established IL-27 signaling pathways. The expression of the IL-27 subunit Ebi3 is elevated in human atheromas, yet its function in atherosclerosis remains unknown. Objective: The aim of this study was to test the role of IL-27 receptor signaling in immune cells in atherosclerosis development. Methods and Results: Atherosclerosis-prone Ldlr −/− mice transplanted with Il27ra −/− bone marrow and fed Western diet for 16 weeks developed significantly larger atherosclerotic lesions in aortic roots, aortic arches, and abdominal aortas. Augmented disease correlated with increased accumulation of CD45 + leukocytes and CD4 + T cells in the aorta, which produced increased amounts of IL-17A and tumor necrosis factor. Several chemokines, including CCL2, were upregulated in the aortas of Ldlr −/− mice receiving Il27ra −/− bone marrow, resulting in accumulation of CD11b + and CD11c + macrophages and dendritic cells in atherosclerotic aortas. Conclusions: The absence of anti-inflammatory IL-27 signaling skews immune responses toward T-helper 17, resulting in increased production of IL-17A and tumor necrosis factor, which in turn enhances chemokine expression and drives the accumulation of proatherogenic myeloid cells in atherosclerotic aortas. These findings establish a novel antiatherogenic role for IL-27 receptor signaling, which acts to suppress the production of proinflammatory cytokines and chemokines and to curb the recruitment of inflammatory myeloid cells into atherosclerotic aortas.
Databáze: OpenAIRE